NEW YORK (GenomeWeb News) – Cepheid today said that the US Food and Drug Administration has granted an Emergency Use Authorization for the firm's Xpert Flu A Panel test.

The test runs on the firm's GeneXpert System and can identify the 2009 H1N1 influenza virus in less than one hour, said Cepheid. In addition, Cepheid said that it is the first test for the virus granted an EUA for CLIA moderate complexity labs, which means it can be performed in hospital near-patient settings.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.

Researchers report that what scents someone picks up can reflect their complement of immune genes.

The New York Times examines ethics and China's push to lead biomedical research.

At her blog, Sally Rockey dives into National Institutes of Health funding data.